Lv2
110 积分 2022-12-11 加入
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial
15天前
已完结
Effects of autophagy on radiosensitivity
2个月前
已完结
[Chinese expert consensus on the watch and wait strategy in rectal cancer patients after neoadjuvant treatment (2024 version)]
2个月前
已完结
Tumor Distribution by Quantitative Mass Spectrometry Imaging of the Inhibitor of Apoptosis Protein Antagonist Xevinapant in Patients with Resectable Squamous Cell Carcinoma of the Head and Neck (EudraCT Number: 2014-004655-31)
8个月前
已完结
Targeting inhibitor of apoptosis proteins (IAPs) enhances susceptibility of oral squamous carcinoma cells to cisplatin
8个月前
已完结
Xevinapant combined with pembrolizumab in patients with advanced, pretreated colorectal and pancreatic cancer: results of the phase 1b/2 CATRIPCA trial
8个月前
已完结
Prognostic value and therapeutic potential of IAP family in head and neck squamous cell carcinoma
9个月前
已完结
Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma
9个月前
已完结
Targeted Options for Glioma Looking Good
1年前
已完结
Dietary interventions and precision nutrition in cancer therapy
1年前
已完结
皖公网安备34019202002308
